Format

Send to:

Choose Destination
See comment in PubMed Commons below

Cholinesterase inhibitors in Alzheimer's disease: supplementary commission rivastigmine patches and galantamine: Executive summary of final report A09-05, Version 1.0.

Source

Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005-.
2012 Feb 03.

Excerpt

The aims of the present investigation were to update the assessment of the benefit of galantamine and to assess the benefit and added benefit of rivastigmine as a transdermal patch in patients with mild to moderate Alzheimer's disease with respect to patient-relevant outcomes.

© IQWiG (Institute for Quality and Efficiency in Health Care).

PMID:
24783277
[PubMed]
Free Books & DocumentsFree full text

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Health
    Loading ...
    Write to the Help Desk